BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/13/2023 10:36:01 AM | Browse: 410 | Download: 1496
 |
Received |
|
2022-10-13 21:31 |
|
Peer-Review Started |
|
2022-10-13 21:34 |
|
First Decision by Editorial Office Director |
|
2022-11-27 05:31 |
|
Return for Revision |
|
2022-11-27 05:31 |
|
Revised |
|
2022-12-31 13:21 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-06-08 03:19 |
|
Second Decision by Editor-in-Chief |
|
2023-06-10 00:46 |
|
Final Decision by Editorial Office Director |
|
2023-06-13 08:52 |
|
Articles in Press |
|
2023-06-13 08:52 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-07-05 12:23 |
|
Publish the Manuscript Online |
|
2023-07-13 08:03 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medical Ethics |
| Manuscript Type |
Opinion Review |
| Article Title |
Access to novel anti-diabetic agents in resource limited settings: A brief commentary
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Poobalan Naidoo, Kiolan Naidoo, Sumanth Karamchand and Rory F Leisegang |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Poobalan Naidoo, BPharm, MBChB, MSc, Academic Research, Doctor, Doctor, Department of Internal Medicine, Nelson R Mandela, School of Medicine, University of Kwa-Zulu Natal, Sydney Road, Umbilo, Durban 4001, Kwa-Zulu Natal , South Africa. poobalan1naidoo@yahoo.com |
| Key Words |
Type 2 diabetes mellitus; Novel anti-diabetic agents; Resource limited settings; Access |
| Core Tip |
The manuscript addresses the problem of access to novel anti-diabetic agents in resource limited settings. Niching therapies for use in those with highest major adverse cardiovascular risk, may limit budget impact for funders. To improve access, and reduce morbidity and mortality, requires alignment amongst key stakeholders including patient advocacy groups, health care professional councils, national departments of health, the pharmaceutical industry, treasury and finance departments. |
| Publish Date |
2023-07-13 08:03 |
| Citation |
Naidoo P, Naidoo K, Karamchand S, Leisegang RF. Access to novel anti-diabetic agents in resource limited settings: A brief commentary. World J Diabetes 2023; 14(7): 939-941
|
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i7/939.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i7.939 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
